Edwards Lifesciences (EW) Other Accumulated Expenses (2009 - 2014)

Edwards Lifesciences' Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $72.6 million for Q4 2014.

• On a quarterly basis, Other Accumulated Expenses rose 2.4% year-over-year to $72.6 million in Q4 2014; TTM through Dec 2014 was $72.6 million, a 2.4% increase from a year earlier, with the FY2014 full-year figure at $72.6 million, up 2.4% from the prior year.
• Other Accumulated Expenses retreated to $72.6 million in Q4 2014 per EW's latest filing, from $82.8 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $82.8 million in Q3 2014 and bottomed at $58.4 million in Q4 2011.
• The 5-year median for Other Accumulated Expenses is $71.3 million (2012), against an average of $69.6 million.
• Across the five-year window, Other Accumulated Expenses declined 4.58% in 2011 and gained 22.77% in 2012, its largest moves.
• Year by year, Other Accumulated Expenses stood at $61.2 million in 2010, then slipped by 4.58% to $58.4 million in 2011, then gained by 22.77% to $71.7 million in 2012, then dropped by 1.12% to $70.9 million in 2013, then advanced by 2.4% to $72.6 million in 2014.
• Per Business Quant, the three latest EW Other Accumulated Expenses figures stand at $72.6 million (Q4 2014), $82.8 million (Q3 2014), and $70.9 million (Q4 2013).